These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1920088)

  • 1. Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.
    Wagner JG; Ganes DA; Midha KK; Gonzalez-Younes I; Sackellares JC; Olson LD; Affrime MB; Patrick JE
    J Pharmacokinet Biopharm; 1991 Aug; 19(4):413-55. PubMed ID: 1920088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of flurbiprofen through human buccal mucosa.
    Gonzalez-Younes I; Wagner JG; Gaines DA; Ferry JJ; Hageman JM
    J Pharm Sci; 1991 Sep; 80(9):820-3. PubMed ID: 1800701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The area function method for assessing the drug absorption rate in linear systems with zero-order input.
    Cheng H; Jusko WJ
    Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of absorption rate constant (ka) following oral administration by Wagner-Nelson, Loo-Riegelman, and statistical moments in the presence of a secondary peak.
    Mahmood I
    Drug Metabol Drug Interact; 2004; 20(1-2):85-100. PubMed ID: 15283305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to estimate the absorption rate constant for two-compartment model fitted drugs without intravenous pharmacokinetic data.
    Liu F; Yi H; Wang L; Cheng Z; Zhang G
    Front Pharmacol; 2023; 14():1087913. PubMed ID: 37214472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Loo-Riegelman absorption method.
    Wagner JG
    J Pharmacokinet Biopharm; 1975 Feb; 3(1):51-67. PubMed ID: 1127578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of variation in drug elimination on five methods for assessing zero-order drug absorption rates.
    Cheng HY; Jusko WJ
    Pharm Res; 1990 Jan; 7(1):76-9. PubMed ID: 2300540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Method for the Estimation of Absorption Rate Constant in Two-Compartment Model by Extravascular Administration.
    Zeng Y; Liu J; Liu W; Jiang S; Wang S; Cheng Z
    J Pharm Sci; 2020 May; 109(5):1802-1810. PubMed ID: 32032589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ibuprofen in man IV: absorption and disposition.
    Wagner JG; Albert KS; Szpunar GJ; Lockwood GF
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):381-99. PubMed ID: 6527231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
    Donnelly R; Macphee GJ
    Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.
    Yu Z; Hwang SS; Gupta SK
    Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple method for the estimation of absorption rate constant(ka) after oral administration.
    Mahmood I
    Am J Ther; 1998 Nov; 5(6):377-81. PubMed ID: 10099080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption.
    Alimpertis N; Tsekouras AA; Macheras P
    Pharm Res; 2023 Sep; 40(9):2167-2175. PubMed ID: 37537424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wagner-Nelson method applied to a multicompartment model with zero order input.
    Wagner JG
    Biopharm Drug Dispos; 1983; 4(4):359-73. PubMed ID: 6661514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of controlled-release products.
    Hwang SS; Bayne W; Theeuwes F
    J Pharm Sci; 1993 Nov; 82(11):1145-50. PubMed ID: 8289130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of the semi-simultaneous method for bioavailability estimation using controlled intravenous infusion as an 'extravascular' route of administration.
    Bredberg U; Karlsson MO
    Biopharm Drug Dispos; 1991 Nov; 12(8):583-97. PubMed ID: 1801965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.
    Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH
    Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diazepam on the pharmacokinetics of intravenous and epidural bupivacaine in the rhesus monkey.
    Thompson GA; Turner PA; Bridenbaugh PO; Stuebing RC; Denson DD
    Anesth Analg; 1986 Feb; 65(2):151-5. PubMed ID: 3942302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.